These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4366970)

  • 1. Virus-augmented tumor transplantation antigens: evidence for a Helper antigen mechanism.
    Boone CW; Paranjpe M; Orme T; Gillette R
    Int J Cancer; 1974 Apr; 13(4):543-51. PubMed ID: 4366970
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation of membrane fractions with enhanced tumor-transplantation-antigen activity from tumor cells infected with influenza virus.
    Boone CW; Orme TW; Blackman K; Gillette R
    J Natl Cancer Inst; 1973 Oct; 51(4):1141-4. PubMed ID: 4355600
    [No Abstract]   [Full Text] [Related]  

  • 3. Augmented immunogenicity of tumor cell membranes produced by surface budding viruses: parameters of optimal immunization.
    Gillette RW; Boone CW
    Int J Cancer; 1976 Aug; 18(2):216-22. PubMed ID: 182646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of influenza virus to growth in cultured murine methylcholanthrene induced tumors.
    Klein PA
    Arch Gesamte Virusforsch; 1974; 45(3):199-208. PubMed ID: 4371624
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmented immunogenicity of tumor cell homogenates produced by infection with influenza virus.
    Boone CW
    Natl Cancer Inst Monogr; 1972 Dec; 35():301-7. PubMed ID: 4349150
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of tumor immunity in mice with antigens prepared from influenza and vesicular stomatitis virus grown in suspension culture of Ehrlich ascites cells.
    Häkkinen I; Halonen P
    J Natl Cancer Inst; 1971 Jun; 46(6):1161-7. PubMed ID: 4325929
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigens.
    Invernizzi G; Parmiani G
    Nature; 1975 Apr; 254(5502):713-4. PubMed ID: 1091865
    [No Abstract]   [Full Text] [Related]  

  • 8. Allogeneic stimulation modulates the in vitro response of T cells to transplantation antigen.
    Lafferty KJ; Misko IS; Cooley MA
    Nature; 1974 May; 249(454):275-6. PubMed ID: 4275319
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissection of a unique tumor-specific transplantation antigen into multiple unique independent epitopes using syngeneic T-cell lines.
    Wortzel RD; Philipps C; Urban JL; Schreiber H
    Haematol Blood Transfus; 1983; 28():489-92. PubMed ID: 6602751
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40.
    Drapkin MS; Appella E; Law LW
    J Natl Cancer Inst; 1974 Jan; 52(1):259-64. PubMed ID: 4129833
    [No Abstract]   [Full Text] [Related]  

  • 12. Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens.
    Fujiwara H; Hamaoka T; Teshima K; Aoki H; Kitagawa M
    Immunology; 1976 Aug; 31(2):239-48. PubMed ID: 1085283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-associated transplantation antigens of myelomas induced in BALB-c mice.
    Williams WH; Krueger RG
    J Natl Cancer Inst; 1972 Dec; 49(6):1613-20. PubMed ID: 4119165
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens.
    Chism SE; Wallis S; Burton RC; Warner NL
    J Immunol; 1976 Nov; 117(5 Pt.2):1870-7. PubMed ID: 993583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors.
    Camenga DL; Nathanson N; Cole GA
    J Infect Dis; 1974 Dec; 130(6):634-41. PubMed ID: 4372273
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-replicating T cells in the immune response of mice. I. Virus plaque assay of the lymphocytes reactive to sheep erythrocytes.
    Minato N; Katsura Y
    J Exp Med; 1977 Feb; 145(2):390-404. PubMed ID: 64584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.